市場調查報告書
商品編碼
1452638
南美洲和中美洲家禽診斷市場預測至 2030 年 - 區域分析 - 按測試類型和疾病(禽沙門氏菌病、禽流感、新城疫、禽支原體病、傳染性支氣管炎等)South & Central America Poultry Diagnostic Market Forecast to 2030 - Regional Analysis - By Test Type and Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others) |
南美洲和中美洲家禽診斷市場預計將從2022年的5,052萬美元成長到2030年的1.0535億美元。預計2022年至2030年CAGR為9.6%。
農場現場診斷家禽平台推動南美洲和中美洲家禽診斷市場
如今,在感染率較高的農場現場安裝了簡單的農場端分子診斷平台和補充監測軟體,透過對家禽動物進行病毒和細菌病原體檢測來遏制疾病傳播。此外,家禽產業團隊可以在短時間內成功開發出符合世界衛生組織 (WHO) 指南的攜帶式、電池供電、獨立的診斷平台,以確保這些設備可以在農場的任何地方運行,從而消除了需要實驗室結構、訓練有素的人員和附加設備。此外,該設備的成本比同類商用設備低 95%,並根據具有同等標準的黃金標準設備進行了驗證。因此,實施此類農場家禽疾病診斷平台將有助於農民透過早期發現和遏制來控制傳染病、抗菌素抗藥性(AMR)和人畜共通病原體的傳播。
南美洲和中美洲家禽診斷市場概述
南美洲和中美洲家禽診斷市場分為巴西、阿根廷以及南美洲和中美洲其他地區。該地區的市場成長主要是由於高致病性禽流感(HPAI)發病率的增加以及為提高食品品質而對家禽診斷的需求不斷成長。泛美衛生組織(PAHO)和世界衛生組織(WHO)已確認高致病性禽流感在南美洲和中美洲的玻利維亞、哥倫比亞、哥斯大黎加、秘魯蔓延。
南美洲和中美洲家禽診斷市場收入及 2030 年預測(百萬美元)
南美洲和中美洲家禽診斷市場細分
南美洲和中美洲家禽診斷市場分為測試類型、疾病和國家。
根據測試類型,南美洲和中美洲家禽診斷市場分為酵素連結免疫吸附測定(ELISA)測試、聚合酶鏈反應(PCR)測試、血凝抑制(HI)等。 2022 年,酵素連結免疫吸附測定 (ELISA) 測試領域在南美洲和中美洲家禽診斷市場中佔據最大佔有率。
疾病方面,南美洲及中美洲家禽診斷市場分為禽流感、傳染性支氣管炎、禽沙門氏菌病、新城疫、禽支原體病等。 2022 年,禽支原體病細分市場在南美洲和中美洲家禽診斷市場中佔據最大佔有率。
依國家分類,南美洲和中美洲家禽診斷市場分為巴西、阿根廷以及南美洲和中美洲其他地區。 2022 年,巴西主導南美洲和中美洲家禽診斷市場。
Thermo Fisher Scientific Inc、Idex Laboratories Inc、Qiagen NV、Eurofins Scientific SE、Boehringer Ingelheim International GmbH、Zoetis Inc 和 BioCheck BV 是南美洲和中美洲家禽診斷市場上的一些領先公司。
The South & Central America poultry diagnostic market is expected to grow from US$ 50.52 million in 2022 to US$ 105.35 million by 2030. It is estimated to grow at a CAGR of 9.6% from 2022 to 2030.
Farm-Side Diagnostic Poultry Platform Fuel South & Central America Poultry Diagnostic Market
Nowadays, a simple farm-side molecular diagnostic platform and complementary surveillance software are installed at the farm site with a high infection rate to curb the spread of disease by test poultry animals for viral and bacterial pathogens. Also, within a short span the poultry industry team can successfully develop a portable, battery-powered, stand-alone diagnostic platform abiding by World Health Organization (WHO) guidelines to ensure that these devices can be operated anywhere on the farm, eliminating the need for laboratory structure, trained personnel, and additional equipment. Also, the cost of the device is 95% lower than comparable commercially available devices and validated against gold standard devices showing equivalent standards. Therefore, implementation of such farm-side poultry disease diagnostic platforms would help farmers keep a check on the spread of infectious disease, antimicrobial resistance (AMR), and zoonotic pathogens by enabling early detection and containment.
South & Central America Poultry Diagnostic Market Overview
The South & Central America Poultry Diagnostics Market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. The market growth in the region is mainly driven by increasing incidence of highly pathogenic avian influenza (HPAI) and rising demand for poultry diagnostics to enhance the quality of food products. The Pan American Health Organization (PAHO) and the World Health Organization (WHO) have confirmed the spread of highly pathogenic avian influenza across Bolivia, Colombia, Costa Rica, Peru, in South & Central America.
South & Central America Poultry Diagnostic Market Revenue and Forecast to 2030 (US$ Million)
South & Central America poultry diagnostic market Segmentation
The South & Central America poultry diagnostic market is segmented into test type, disease, and country.
Based on test type, the South & Central America poultry diagnostic market is segmented into enzyme-linked immunosorbent assay (ELISA) tests, polymerase chain reaction (PCR) tests, hemagglutination-inhibition (HI), and others. The enzyme-linked immunosorbent assay (ELISA) tests segment held the largest share of the South & Central America poultry diagnostic market in 2022.
In terms of disease, the South & Central America poultry diagnostic market is segmented into avian influenza, infectious bronchitis, avian salmonellosis, Newcastle disease, avian mycoplasmosis, and others. The avian mycoplasmosis segment held the largest share of the South & Central America poultry diagnostic market in 2022.
By country, the South & Central America poultry diagnostic market is segmented int o Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America poultry diagnostic market in 2022.
Thermo Fisher Scientific Inc, Idexx Laboratories Inc, Qiagen NV, Eurofins Scientific SE, Boehringer Ingelheim International GmbH, Zoetis Inc, and BioCheck BV are some of the leading companies operating in the South & Central America poultry diagnostic market.